Results 91 to 100 of about 3,395,761 (154)

The evaluation of myocardial protection using blood cardioplegic solution versus crystalloid cardioplegic solution : study in an isolated heart model

, 2018
Orientador: Orlando Petrucci JuniorTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências MédicasResumo: INTRODUÇÃO: O efeito deletério provocado pela isquemia e reperfusão do miocárdio durante a parada cardíaca apresenta-se como uma
Carmo, Helison Rafael Pereira do, 1986-
core  

Experimental Study of Cold Blood Cardioplegic Solution. Is Cold Blood Cardioplegic Solution made Effective by the Red Blood Cell?

This sutudy was designed to distinguish whether the efficacy of blood cardioplegic solution is due to a celluler or plasma component. Japanese white rabbits' hearts were preserved for 3 hours by coronary perfusion with oxygenated crystalloid cardioplegic
Kawamura, Tsutomu
core  

A multi-center, open label, single group, observational clinical trial to investigate the effects of training on the administration of Cardioplexol™

Frontiers in Cardiovascular Medicine
IntroductionCardioplexol™ was recently proven effective and non-inferior to Buckberg's solution in a pivotal Phase-3 clinical trial. We hypothesized here that a standardized training program for surgeons without prior experience of Cardioplexol™ could ...
Hendrik T. Tevaearai Stahel, Niuscha Taheri, Andreas Winkler, Johannes Hohlfeld, Wolfgang Dietl, Christoph Starck, Arnaud Van Linden, Jan Bidovec, Aaron Imhof, Thierry P. Carrel, Bernard Voet, Thomas Walther, Rainald Seitelberger, Michael Grimm, Christoph Holzinger, Martin Grabenwöger, Martin Grabenwöger, Martin Grabenwöger   +17 more
doaj   +1 more source

The safe interval time of crystalloid cardioplegic solution transfusion during CABG

Iranian South Medical Journal, 2015
Background: Cold crystalloid cardioplegic solution is used for cardiac arrest and myocardial protection during CABG intermittently. There is no defined safety interval time for cardioplegia infusion.
Ebrahim Shafiei, Zinat Fouladi, Parham Shafiei   +2 more
doaj  

Evaluating the need for magnesium administration following cardioplegic arrest with del Nido cardioplegia solution

The Journal of ExtraCorporeal Technology
Background: del Nido cardioplegia (dNC) solution is widely used in pediatric and congenital cardiac surgery. In 2014, Cincinnati Children’s Hospital Medical Center (CCHMC) changed from Mee cardioplegic solution to dNC. Since Mee solution does not contain
Whittaker Striker Carrie, Reagor James A.   +1 more
doaj   +1 more source

Myocardial Protective Effects of Nicardipine Hydrocloride (Perdipine) in Glucose Potassium Cardioplegic Solution on Isolated Rat Heart [PDF]

The effect on myocardial protection against ischemic damage by addition of the Ca antagonist perdipine (nicardipine) at 0.25mg/L, and 0.5mg/L, to cardioplegic solution on isolated rat heart was assessed by hemodynamic studies, the time required to ...
Kawabe, Hideaki
core   +1 more source

A randomized comparison of crystalloid and blood-containing cardioplegic solutions in 60 patients.

, 1984
To determine whether adding blood to a cardioplegic solution affects myocardial preservation, a randomized prospective study was carried out in 60 patients undergoing coronary revascularization to compare the effects of crystalloid potassium ...
J G Reves, L R Smith, H G McDaniel, E E Buttner, C Brummett, G Kreusch, S Oparil, R B Karp   +7 more
core   +1 more source

Cardioplegic rearrest: clinical experience with 12 patients

, 1981
Myocardial damage due to ischemic arrest occurs during aortic unclamping and early reoxygenation (reperfusion injury). Thus, surgeons may be reluctant to reinfuse cardioplegic agents if a second period of aortic cross-clamping is required at the end of ...
Neilson, I R, Charrette, E J, Salerno, T A, Chiong, M A   +3 more
core   +3 more sources

Anterograde vs Antero-/Retrograde del Nido Cardioplegia in Aortic Valve Surgery

Acta Clinica Croatica
Background: Myocardial protection involves different methods aimed at preventing or reducing ischemia-reperfusion damage to the myocardium during surgery to preserve postoperative heart function.
Nail Šehić, Dragan Piljić, Emin Grbić, Alen Hajdarević, Mugdim Bajrić   +4 more
doaj   +1 more source

Type of cardioplegic solution as a factor influencing the clinical outcome of open-heart congenital procedures. [PDF]

Kardiochir Torakochirurgia Pol, 2018
Sobieraj M, Kilanowska M, Ładziński P, Garbuzowa I, Wojtalik M, Moczko J, Mrówczyński W.   +6 more
europepmc   +1 more source